← Leaderboards
Nader H Moniri
Mercer University Macon
$1,645,025
Attributed
$1,838,900
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $539.8K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,838,900 · 4
By mechanism
R15$1,296,930 · 2
R21$387,750 · 1
R03$154,220 · 1
Top collaborators
- Clinton E Canal1 shared
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorMediatingAgonistEtiologySignal TransductionG-Protein-Coupled ReceptorsKnowledge BaseCell LineFunctional DisorderGoldLaboratoriesPhysiologicalStandard CareTissuesLeadPathway InteractionsGtp-Binding ProteinsInterestPhosphorylationEpinephrineCyclic AmpCoupledEnzymesAnimal Model
Grant awards (6)
Molecular pharmacology of xylazine at adrenoceptors: Relation to necrotic skin lesions associated with chronic intravenous administration$387,750
R21 · FY2024 · DA
The role of ROS on beta-2-adrenergic receptor function in human airway$424,500
R15 · FY2022 · HL · contact PI
The role of ROS on beta-2-adrenergic receptor function in human airway$462,660
R15 · FY2017 · HL · contact PI
FFAR4 and nigrostriatal function: A novel target for treatment of PD?$77,110
R03 · FY2017 · NS · contact PI
FFAR4 and nigrostriatal function: A novel target for treatment of PD?$77,110
R03 · FY2016 · NS · contact PI
The role of phosphorylation in regulating the antidiabetic effects of O3FAR-1$409,770
R15 · FY2013 · DK · contact PI